Key facts
| Price (PPV) | 37.70 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amoxicilline |
| Class | Antibacterials for systemic use |
| ATC code | J01CA04 |
| Manufacturer | PHARMA5 |
| Presentation | 2 flacons de 60 ml |
| Hospital price | 23.50 MAD |
| Data collected on | 9/8/2026 |
Indications
L’amoxicilline est indiquée dans le traitement des infections suivantes chez l’adulte et l’enfant: - Sinusite bactérienne aiguë, - Otite moyenne aiguë, - Angine/pharyngite documentée à streptocoque, - Exacerbations aigües de bronchite chronique, - Pneumonie communautaire, - Cystite aiguë, - Bactériurie asymptomatique gravidique, - Pyélonéphrite aiguë, - Fièvre typhoïde et paratyphoïde, - Abcès dentaire avec cellulite, - Infections articulaires sur prothèses, - Eradication de Helicobacter pylori, - Maladie de Lyme. L’amoxicilline est aussi indiquée dans la prophylaxie de l’endocardite. Il convient de tenir compte des recommandations officielles concernant l'utilisation appropriée des antibactériens.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Streptocid 250 mg / 5ml (PHARMA5) contains the same active substance as Alfamox 250 mg / 5ml (Amoxicilline) at the same strength, but in a different pack: Flacon de 60 ml at 22.40 MAD, i.e. 0.37 MAD per ml against 0.63 MAD for Alfamox 250 mg / 5ml. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Streptocid 250 mg / 5ml | PHARMA5 | Flacon de 60 ml | 22.40 MAD | 0.37 / ml |
| Pneumoccid 250 mg / 5ml | PHARMA5 | Boîte de 2 flacons de 60 ml | 37.70 MAD | 18.85 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Alfamox 250 mg / 5ml
Alfamox 250 mg / 5ml belongs to the antibacterials for systemic use therapeutic class. In Morocco, this drug is marketed by PHARMA5 and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Alfamox 250 mg / 5ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Alfamox 250 mg / 5ml
Answers to common questions from Moroccan patients about this drug.